Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,153 | 20,611 | 28,415 | 21,136 | 26,301 |
| Marketable Securities | 56,482 | 4,992 | 9,932 | 21,860 | 26,774 |
| Other current assets | 4,733 | 3,221 | 3,742 | 2,925 | 2,865 |
| TOTAL | $74,368 | $28,824 | $42,089 | $45,921 | $55,940 |
| Non-Current Assets | |||||
| PPE Net | 252 | 269 | 285 | 346 | 433 |
| Investments And Advances | 62,773 | 20,908 | 20,908 | 20,908 | 20,974 |
| Other Non-Current Assets | 13,541 | 13,847 | 14,146 | 14,479 | 14,820 |
| TOTAL | $76,566 | $35,024 | $35,339 | $35,733 | $36,227 |
| Total Assets | $150,934 | $63,848 | $77,428 | $81,654 | $92,167 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,956 | 1,710 | 3,950 | 1,950 | 3,192 |
| Accrued Expenses | 4,899 | 2,959 | 2,872 | 5,997 | 5,994 |
| TOTAL | $8,288 | $6,796 | $8,924 | $9,307 | $10,522 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 718 | 718 | N/A | N/A |
| TOTAL | $11,986 | $12,354 | $12,715 | $13,070 | $13,419 |
| Total Liabilities | $20,274 | $19,150 | $21,639 | $22,377 | $23,941 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,875 | 71,212 | 71,110 | 71,110 | 71,075 |
| Common Shares | 130 | 71 | 71 | 71 | 71 |
| Retained earnings | -321,713 | -331,376 | -319,218 | -314,533 | -304,299 |
| Other shareholders' equity | -202 | -126 | -69 | -48 | -35 |
| TOTAL | $130,660 | $44,698 | $55,789 | $59,276 | $68,226 |
| Total Liabilities And Equity | $150,934 | $63,848 | $77,428 | $81,653 | $92,167 |